Japan Scrambles to Recall SPL-made Heparin
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Under the guidance of Japan's Ministry of Health, Labor and Welfare, Fuso Pharmaceutical Industries, Otsuka Pharmaceutical and Terumo Corp. work to replace their heparin sodium products that contain active ingredients from Scientific Protein Laboratories